Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hervé Bachelez

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Lancet (London, England)|June 15, 2015
Interleukin-17 inhibition: a route to psoriasis clearance?Hervé Bachelez
The British Journal of Dermatology|May 3, 2022
Is heat shock protein 90 inhibition a relevant treatment strategy for psoriasis?Hervé Bachelez
Journal of Autoimmunity|November 3, 2005
Immunopathogenesis of psoriasis: recent insights on the role of adaptive and innate immunityHervé Bachelez
Lancet (London, England)|June 10, 2017
Interleukin 23 inhibitors for psoriasis: not just another numberHervé Bachelez
La Revue Du Praticien|June 23, 2007
[Cutaneous lymphomas]Hervé Bachelez
Experimental Dermatology|February 3, 2016
Chemokine ligand 7 (CCL7) and innate immune cells in psoriasis: beyond redundancyHervé Bachelez
JAAD Case Reports|November 22, 2017
Radiation-induced inflammatory dermatosis: Another facet of the immunocompromised cutaneous districtRoger Haber, Hervé Bachelez
La Revue Du Praticien|March 31, 2004
[Prescribing immunosuppressive and immunomodulatory drugs in psoriasis]Mathilde Kemula, Hervé Bachelez
Journal of the American Academy of Dermatology|August 18, 2020
Reply to: Comment on "Sirolimus as combination rescue therapy with tumor necrosis alpha inhibitors for severe, refractory hidradenitis suppurativa"Thomas Bettuzzi, Hervé Bachelez
The Journal of Allergy and Clinical Immunology|May 5, 2020
ReplyHervé Bachelez, Florence Assan
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Lancet (London, England)|June 15, 2015
Interleukin-17 inhibition: a route to psoriasis clearance?Hervé Bachelez
The British Journal of Dermatology|May 3, 2022
Is heat shock protein 90 inhibition a relevant treatment strategy for psoriasis?Hervé Bachelez
Journal of Autoimmunity|November 3, 2005
Immunopathogenesis of psoriasis: recent insights on the role of adaptive and innate immunityHervé Bachelez
Lancet (London, England)|June 10, 2017
Interleukin 23 inhibitors for psoriasis: not just another numberHervé Bachelez
La Revue Du Praticien|June 23, 2007
[Cutaneous lymphomas]Hervé Bachelez
Experimental Dermatology|February 3, 2016
Chemokine ligand 7 (CCL7) and innate immune cells in psoriasis: beyond redundancyHervé Bachelez
JAAD Case Reports|November 22, 2017
Radiation-induced inflammatory dermatosis: Another facet of the immunocompromised cutaneous districtRoger Haber, Hervé Bachelez
La Revue Du Praticien|March 31, 2004
[Prescribing immunosuppressive and immunomodulatory drugs in psoriasis]Mathilde Kemula, Hervé Bachelez
Journal of the American Academy of Dermatology|August 18, 2020
Reply to: Comment on "Sirolimus as combination rescue therapy with tumor necrosis alpha inhibitors for severe, refractory hidradenitis suppurativa"Thomas Bettuzzi, Hervé Bachelez
The Journal of Allergy and Clinical Immunology|May 5, 2020
ReplyHervé Bachelez, Florence Assan
Pageof 13